Neurostimulation sales will expand through 2036, with spinal cord stimulators holding 48.0% of the product type segment in 2026, driven by clinical adoption and regulatory compliance requirements. The market was valued at USD 7.40 billion in 2025 and is expected to be worth USD 19.48 billion by 2036.